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Background: Cardiac resynchronization therapy (CRT) and implantable
cardioverter-defibrillators (ICD) are effective therapies for heart failure (HF)
patients with cardiac dyssynchrony. Patients receiving primary prevention
CRT-D that positively remodel may no longer qualify for ICD indication due
to CRT induced left ventricular ejection fraction (LVEF) improvement. 
Objective: We aimed to evaluate the outcome of CRT-D patients at the
time of device replacement (DR). Methods: Patients undergoing primary pre-
vention CRT-D DR were prospectively included from November 2007 to
March 2011 in two centers. CRT response was as a ≥1 NYHA class improve-
ment and an increase in LVEF≥10%. Six months before DR, all patients
underwent echocardiography and device interrogation. Patients without theo-
retical ongoing ICD indication (TOII) at DR were defined as those with
LVEF≥40% without appropriate ICD therapy (AT) during the first ICD ser-
vice-life. 
Results: A total of 107 consecutive patients were enrolled. Sixty-one
patients (57%) were considered CRT responders after the index procedure. At
the time of DR (56.4±14.4 months from initial implant), 87% of CRT
responders were free of AT, compared with 70% of non CRT-responders
(p=0.02). Thirty-nine patients (36%) did not meet the criteria for TOII. During
follow-up (mean 26.4±14.4 months after DR) 37 patients (95%) without TOII
were free of AT versus 49 of 68 patients (72%) with ongoing TOII (p=0.007).
By multivariable analysis the only independent predictor of AT after DR was
TOII (hazard ratio=6.43;p=0.01).
Conclusion: Absence of theoretical ICD indication occurs in more than
one third of CRT-D patients undergoing DR. In addition AT rate is relatively
low (2.2%/year) in this subgroup of patients.
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Safety and effectiveness of transvenous lead extraction in octogenarians. 
Introduction: As the median population ages, the number of elderly
patients with implantable cardiac devices referred for transvenous lead extrac-
tion will dramatically increase. The safety and effectiveness of lead extraction
in elderly patients has not been well evaluated. We report the safety and effec-
tiveness of transvenous lead extraction in octogenarians.
Methods and results: From January 2002 to December 2013, we reviewed
data from consecutive patients more than 80 years referred to our institution
for transvenouslead extraction for infection or lead dysfonction.
Clinical characteristics, procedural features, and periprocedural major and
minor complications were compared between octogenarians and younger
patients. Out of 391 patients undergoing lead extraction during the study
period, 100 (25,6%) patients were octogenarians (mean age 84,24 years; range
80-98; 75 % males).
A significantly higher percentage of octogenarians presented with chronic
renal failure (P=0,03), history of malignancy ( P =0,04)
Infection was the most common reason for lead extraction in elderly (82%
of cases).Laser assistance for extraction was recquired in 69 elderly patients
(69%)
Complete lead extraction efficacy were similar between both groups (99%
in octogenarians vs 98,6% in patients <80 years; P =0,6).
No deaths occurred in the octogenarian group. No differences in terms of
other periprocedural major and minor complications were found between the
2 groups. 
Conclusion: Despite a significantly higher rate of comorbidities, transve-
nouslead extraction can be performed safely and successfully in octogenarians
with a low rate of complications 
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Purpose: Remote monitoring (RM) is now accepted as a safe alternative
to standard follow-up (sFU) for ICD.
Methods: We analyzed the long term arrhythmic events and device-related
outcomes of 843 ICD/CRT-D.
Patients (pts) were equipped with Boston (44%), Medtronic (40%), St Jude
Medical (11%), Biotronik (3%) and Sorin (2%) RM systems. FU started after
hospital discharge. Automatic FU with RM was performed every 3 months,
with at least one sFU /year. In emergency cases, pts were invited for in-
hospital control visits.
ICDs were programmed with 2 zones (VT zone >180 bpm / VF zone
>220bpm). All RM alerts and related EGMs as well as the reasons of therapies
were reviewed by two physicians.
Results: 843 pts (82% male, 64±10 y.o.) were enrolled. 52% had ischemic
cardiomyopathy, 44% previous history of AF. 63% were primary prevention
ICDs. CRT (46%) and dual chamber (44%) were mainly represented, single
chamber 10%.
During a FU period of 28±14 months, we noted 16±11 automatic RM FU
and 2±1 sFU visits/patient. 87 pts died during FU. 92 pts had major alerts (37
for ICD lead dysfunction, 33 for ERI reached, 18 for electrical storm, 4 the-
rapies off). Within 216 pts with minor alerts, 112 refer to AF, with for 54 pts
early detection of unknown AF resulting in therapy modifications. 
238 appropriate (app) shocks occurred in 73 pts (9%). 57 inappropriate
shocks occurred in 23 pts (3%) and were mainly due to AF (61%, other: sinus
tachycardia 9%, lead dysfunction 13%, T oversensing 9%, electromagnetic
interference 4%).
141 pts had app ATP (17% of the population). 14 pts with high LV lead
impedance detected by RM had LV lead dislodgement and underwent early
intervention.
Conclusion: In a large single center observational study, RM has demon-
strated to be an effective method of FU for ICD recipients. Early diagnoses of
AF or lead failure allow rapid management of patients and are associated with
a very low rate of inappropriate shocks. 
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Background: The life-saving benefit of implantable cardioverter defibril-
lators (ICD) has been well demonstrated, and therefore their utilization has
considerably grown in the last 10 years. At the same time, complications have
become an increasingly important concern.
Objectives: This study aimed to assess the prevalence and impact on out-
comes (late complications and overall mortality) of early complications after
ICD implantation for primary prevention in a large French population.
